Clinical trial
Role of the Bioimpedance Analysis in Guiding the Diuretic Therapy in Chronic Heart Failure - A Randomized Controlled Trial
NCT02662439 is registered in ClinicalTrials.gov with Peter Studinger as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of the Bioimpedance Analysis in Guiding the Diuretic Therapy in Chronic Heart Failure - A Randomized Controlled Trial
- Lead sponsor
- Peter Studinger
- Phase
- Not applicable
- Overall status
- Suspended
- Start date
- February 29, 2016
- Completion date
- Not reported
- Enrollment
- 240 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.